MYC increases breast cancer stem cell-like properties and EMT by binding to DOT1L and p300, which stimulates SNAIL, ZEB1, ZEB2 transcription and promotes lysine-79 methylation and H3 acetylation through gene epigenetic modification 58. This evidence concerns the gene SNAI1 and breast carcinoma.